TRIALODINE Drug Patent Profile
✉ Email this page to a colleague
When do Trialodine patents expire, and when can generic versions of Trialodine launch?
Trialodine is a drug marketed by Quantum Pharmics and is included in one NDA.
The generic ingredient in TRIALODINE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trialodine
A generic version of TRIALODINE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIALODINE?
- What are the global sales for TRIALODINE?
- What is Average Wholesale Price for TRIALODINE?
Summary for TRIALODINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,664 |
| DailyMed Link: | TRIALODINE at DailyMed |
Recent Clinical Trials for TRIALODINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Butler Hospital | Phase 3 |
| National Institute on Drug Abuse (NIDA) | Phase 3 |
US Patents and Regulatory Information for TRIALODINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quantum Pharmics | TRIALODINE | trazodone hydrochloride | TABLET;ORAL | 070942-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
